Joost P.H. Drenth

43.9k citations

699 papers · 24.3k indexed · 4 hit papers · h-index 79

Impact in

Hepatology top 0.2%
- Liver Diseases and Immunity
Genetics top 0.1%
- Genetic and Kidney Cyst Diseases

Papers in

Hepatology 124
- Hepatitis C virus research 61
- Liver Diseases and Immunity 44
Medical Terminology 2

Co-authors: Bauke W. Dijkstra Kor H. Kalk J.W.M. van der Meer Wim G. J. Hol Stephen G. Waxman K.H. Kalk Anna Simon René H. M. te Morsche
Journals: Journal of Hepatology (30 papers)Liver International (20 papers)Journal of Molecular Biology (19 papers)Alimentary Pharmacology & Therapeutics (17 papers)European Journal of Gastroenterology & Hepatology (14 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Joost P.H. Drenth

662 papers receiving 23.3k citations

Hit Papers

align trajectories log scale

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis 2013 · 472 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Hepatology
1984 Journal of Molecular Biology
1983 Journal of Molecular Biology
1968 Nature

Peers

Countries citing papers authored by Joost P.H. Drenth

Since Specialization

Citations

This map shows the geographic impact of Joost P.H. Drenth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost P.H. Drenth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost P.H. Drenth more than expected).

Fields of papers citing papers by Joost P.H. Drenth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost P.H. Drenth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost P.H. Drenth. The network helps show where Joost P.H. Drenth may publish in the future.

Co-authors

The 25 scholars most cited alongside Joost P.H. Drenth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joost P.H. Drenth Line = papers co-authored together Joost P.H. Drenth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial Trials ·Ageng Puspita Ayu Anggraeni, Christian Gerges, Erik J. Schoon, Putu Esa Naranata Dewi, Albina R. Nabieva, 亚杰梁, Torsten Beyna, Joost P.H. Drenth, Safira Dewi Purnama, Peter D. Siersema, Erwin J. M. van Geenen, (unknown)	2024	1
2	The pathophysiology of polycystic liver disease Journal of Hepatology ·Mohan N. Vishwanathan, Raffaella Ruggiero, Tom J.G. Gevers, Joost P.H. Drenth	2024	3
3	Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients Surgery ·William Almonacid González, Cameron Rempel, wencai lu, K Eckert, Marjorie Gould, Joost P.H. Drenth, Jithin Mathews, L Sandonato, Philip R. de Reuver, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	1
4	Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapy HPB ·Thijs R.M. Barten, Weiqiu Ding, Marie C. Hogan, Tom J.G. Gevers, Joost P.H. Drenth	2023	2
5	Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study Liver International ·Sebastian Poggel, Anders Boyd, Sylvia M. Brakenhoff, Ramón Trías, Rosan A van Zoest, Mark D. Verhagen, Robert J. de Knegt, Joost P.H. Drenth, Marc van der Valk, (unknown)	2023	2
6	Research gaps and opportunities in autoimmune hepatitis—Results of the international autoimmune hepatitis group research workshop 2022 Liver International ·Romée J.A.L.M. Snijders, David N. Assis, Ye Htun Oo, Marcial Sebode, Richard Taubert, José Willemse, M Kamada, Ansgar W. Lohse, Joost P.H. Drenth, Tom J.G. Gevers, (unknown)	2023	10
7	Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis European Heart Journal ·王伟平 Wang Weiping, Н Н Соловьёв, Jiong-lou Xu, 松井勝, Marleen van Wely, Laura Rodwell, Niels van Royen, Joost P.H. Drenth, L Q Wang	2023	10
8	Noninvasive Staging of Hepatic Steatosis Using Calibrated 2D US with Liver Biopsy as the Reference Standard Radiology ·Gert Weijers, Isabelle D Munsterman, J.M. Thijssen, روشنک اسدی تبریزی, Joost P.H. Drenth, Eric T.T.L. Tjwa, Chris L. de Korte	2022	3
9	Reduction of Gastrointestinal Bleeding in Patients With Heyde Syndrome Undergoing Transcatheter Aortic Valve Implantation Circulation Cardiovascular Interventions ·王伟平 Wang Weiping, Н Н Соловьёв, Christine Leber-Anderwald, Reinier Akkermans, E. S. Zegers, Ron Pisters, Marleen van Wely, Georges-S. Colin, Joost P.H. Drenth, Erwin J. M. van Geenen, Niels van Royen	2022	12
10	Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex Cells ·Г В Осадчий, Sven Lang, Florian Bochen, Andreas Roos, Joost P.H. Drenth, I Iavicoli, Richard Zimmermann, Maximilian Linxweiler	2021	27
11	The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030 Journal of Clinical Medicine ·Sebastian Poggel, Sylvia M. Brakenhoff, Ramón Trías, Wei‐Han Cheng, Hans Blokzijl, Greet J. Boland, Anthonius S. M. Dofferhoff, Bart van Hoek, Cees van Nieuwkoop, Milan J. Sonneveld, Marc van der Valk, Joost P.H. Drenth, Robert J. de Knegt	2021	6
12	Screening for abnormal glycosylation in a cohort of adult liver disease patients Journal of Inherited Metabolic Disease ·Jos C. Jansen, Bart van Hoek, Herold J. Metselaar, Aad P. van den Berg, Fokje Zijlstra, Karin Huijben, Monique van Scherpenzeel, Joost P.H. Drenth, Dirk J. Lefeber	2020	8
13	Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis Clinical Gastroenterology and Hepatology ·Simon Pape, Tom J.G. Gevers, Tae Lim Sin, Gerhard Ernst, Jan Maarten Vrolijk, Bart van Hoek, Gerd Bouma, Carin M.J. van Nieuwkerk, Johannes Hartl, Christoph Schramm, Ansgar W. Lohse, Richard Taubert, Elmar Jaeckel, Michael P. Manns, Mária Papp, Felix Stickel, Michael A. Heneghan, Joost P.H. Drenth	2019	45
14	Safe use of proton pump inhibitors in patients with cirrhosis British Journal of Clinical Pharmacology ·Teda Water, Margriet Bouma, David M. Burger, Joost P.H. Drenth, Ayo Ogundero, Nicole Hunfeld, Herold J. Metselaar, A. Merino, Erma Yulia, Katja Taxis, Sander D. Borgsteede	2018	35
15	Ribavirin steady‐state plasma level is a predictor of sustained virological response in hepatitis C–infected patients treated with direct‐acting antivirals Alimentary Pharmacology & Therapeutics ·正美椿, Cássio Vieira Marques dos Santos, Elise J. Smolders, Karel J. van Erpecum, Abduelrahman Adam Omer, Raoel Maan, Marc van der Valk, Joop E. Arends, Anthonius S. M. Dofferhoff, Hans Blokzijl, Nikolas Löbel, Joost P.H. Drenth, Robert J. de Knegt, David M. Burger, (unknown)	2017	2
16	The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection. PubMed ·Erik H.C.J. Buster, Bert C. Baak, C. M. Bakker, Ulrich Beuers, Johannes T. Brouwer, Joost P.H. Drenth, Karel J. van Erpecum, Bart van Hoek, Pieter Honkoop, 勝美寄本, Ger H. Koek, Karin M.J. van Nieuwkerk, S. Zator, Ajay Kumar Rajbhandari, Adriaan C.I.T.L. Tan, Linyang Xie, Harry L.A. Janssen	2012	7
17	The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes Alimentary Pharmacology & Therapeutics ·Manuel Garra, Minneke J. Coenraad, Henk R. van Buuren, Robert A. de Man, Karel J. van Erpecum, 正人石原, Joost P.H. Drenth, Nataliia Lytvynenko, Ulrich Beuers, A. Platt, Ger H. Koek, Carin M.J. van Nieuwkerk, (unknown), J.T. Brouwer, Bart van Hoek	2011	75
18	NaV1.7 Gain-of-function Mutations As A Continuum: A1632E Displays Physiological Changes Associated With Erythromelalgia And Paroxysmal Extreme Pain Disorder Mutations And Produces Symptoms Of Both Disorders Biophysical Journal ·Mark Estación, Sulayman D. Dib‐Hajj, Paul J. Benke, René H. M. te Morsche, Emmanuella M. Eastman, Lawrence J. Macala, Joost P.H. Drenth, Stephen G. Waxman	2009	50
19	Tropical calcific pancreatitis and its association with CTRC and SPINK1 (p.N34S) variants European Journal of Gastroenterology & Hepatology ·구경완Kyung-Wan Koo, Richárd Szmola, René H. M. te Morsche, 吳壽山; 許和鈞; 顧廣平, Ashok Chacko, Joost P.H. Drenth	2009	19
20	Assessment and selection in organizations : methods and practice for recruitment and appraisal J. Wiley eBooks ·Peter Herriot, Joost P.H. Drenth, Neil Anderson	1989	37

About Joost P.H. Drenth

Joost P.H. Drenth is a scholar working on Hepatology, Medical Terminology, Genetics, Gastroenterology and Epidemiology, having authored 699 papers that have together received 24.3k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (114 papers), Liver Disease Diagnosis and Treatment (112 papers), Hepatitis C virus research (61 papers), Pediatric Hepatobiliary Diseases and Treatments (51 papers), Gallbladder and Bile Duct Disorders (47 papers), Liver Diseases and Immunity (44 papers), Pancreatic and Hepatic Oncology Research (37 papers) and Inflammasome and immune disorders (36 papers). The work is most often cited by research in Hepatology (3.0k citations), Genetics (5.2k citations), Molecular Biology (10.4k citations), Immunology (2.7k citations) and Nephrology (853 citations). Joost P.H. Drenth has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Bauke W. Dijkstra, Kor H. Kalk, J.W.M. van der Meer, Wim G. J. Hol, Stephen G. Waxman, K.H. Kalk, Anna Simon, René H. M. te Morsche, Tom J.G. Gevers and Jos W.M. van der Meer. Their work appears in journals such as Journal of Hepatology, Liver International, Journal of Molecular Biology, Alimentary Pharmacology & Therapeutics and European Journal of Gastroenterology & Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact